Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | Journal Article |
PMID | (23258168) |
Authors | Anastas JN, Moon RT |
Title | WNT signalling pathways as therapeutic targets in cancer. |
Journal | Nature reviews. Cancer |
Vol | 13 |
Issue | 1 |
Date | 2013 Jan |
URL | |
Abstract Text | Since the initial discovery of the oncogenic activity of WNT1 in mouse mammary glands, our appreciation for the complex roles for WNT signalling pathways in cancer has increased dramatically. WNTs and their downstream effectors regulate various processes that are important for cancer progression, including tumour initiation, tumour growth, cell senescence, cell death, differentiation and metastasis. Although WNT signalling pathways have been difficult to target, improved drug-discovery platforms and new technologies have facilitated the discovery of agents that can alter WNT signalling in preclinical models, thus setting the stage for clinical trials in humans. |
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|---|---|---|---|---|
CTNNB1 | S45C | missense | gain of function - predicted | CTNNB1 S45C lies within a Gsk3b phosphorylation site on the Ctnnb1 protein (UniProt.org). S45C has not been characterized, however other S45 “hotspot” mutations are activating (PMID: 15579438, PMID: 23258168), and therefore, S45C is predicted to result in a gain of Ctnnb1 protein function. | |
CTNNB1 | S45N | missense | gain of function - predicted | CTNNB1 S45N lies within a Gsk3b phosphorylation site on the Ctnnb1 protein (UniProt.org). S45N has not been characterized, however, other S45 “hotspot” mutations are activating (PMID: 15579438, PMID: 23258168), and therefore, S45N is predicted to result in a gain of Ctnnb1 protein function. |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|